Davis Polk advised Royalty Pharma plc on the transaction.Royalty Pharma executed its offering of $1.3 billion aggregate principal amount of senior notes. The offering consisted of $600…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now